Niels van de Donk

PROF.DR., (Principal Investigator)


Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output


A phase II study of selinexor(KPT-330) combined with bortezomib and dexamethasone (SVD) for induction and consolidation for patients with progressive or refractory multiple myeloma: The selvedex trial

Broijl, A., Asselbergs, E. L., Minnema, M. C., Lonergan, S., van der Holt, B., van de Donk, N., Zweegman, S. & Sonneveld, P., 2018, (Congr Eur Hematol Assoc (EHA) SO - Congr Eur Hematol Assoc (EHA))

Research output: Book/ReportBookAcademicpeer-review